Skip to content

5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide

C21H22F3N5O3 — CID 171534855

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide
SMILESCc1cnc(C(=O)NC(c2nc3cc(OC(F)(F)F)ccc3n2C)C2CCCOC2)cn1
InChIInChI=1S/C21H22F3N5O3/c1-12-9-26-16(10-25-12)20(30)28-18(13-4-3-7-31-11-13)19-27-15-8-14(32-21(22,23)24)5-6-17(15)29(19)2/h5-6,8-10,13,18H,3-4,7,11H2,1-2H3,(H,28,30)
InChIKeyVLRHFGIFIFKOAR-UHFFFAOYSA-N
MW449.43 g/mol
LogP3.47
Rot. Bonds5

About 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide

5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide (PubChem CID 171534855) has the molecular formula C21H22F3N5O3 and a molecular weight of 449.43 g/mol. Its IUPAC name is 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide.

Molecular Properties

Compound Name5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide
PubChem CID171534855
Molecular FormulaC21H22F3N5O3
Molecular Weight449.43 g/mol
Exact Mass449.17
IUPAC Name5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide
SMILESCc1cnc(C(=O)NC(c2nc3cc(OC(F)(F)F)ccc3n2C)C2CCCOC2)cn1
InChIInChI=1S/C21H22F3N5O3/c1-12-9-26-16(10-25-12)20(30)28-18(13-4-3-7-31-11-13)19-27-15-8-14(32-21(22,23)24)5-6-17(15)29(19)2/h5-6,8-10,13,18H,3-4,7,11H2,1-2H3,(H,28,30)
InChIKeyVLRHFGIFIFKOAR-UHFFFAOYSA-N
XLogP3.47
TPSA91.16 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms32
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500449.43
LogP ≤ 53.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide?
The IUPAC name of 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide (CID 171534855) is 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide.
What is the SMILES notation for 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide?
The canonical SMILES for 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide is Cc1cnc(C(=O)NC(c2nc3cc(OC(F)(F)F)ccc3n2C)C2CCCOC2)cn1.
What is the InChIKey of 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide?
The InChIKey is VLRHFGIFIFKOAR-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H22F3N5O3/c1-12-9-26-16(10-25-12)20(30)28-18(13-4-3-7-31-11-13)19-27-15-8-14(32-21(22,23)24)5-6-17(15)29(19)2/h5-6,8-10,13,18H,3-4,7,11H2,1-2H3,(H,28,30).
What are the key properties of 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide?
5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide has a molecular weight of 449.43 g/mol, XLogP of 3.47, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-methyl-N-[[1-methyl-5-(trifluoromethoxy)benzimidazol-2-yl]-(oxan-3-yl)methyl]pyrazine-2-carboxamide is sourced from PubChem (CID 171534855), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.